Chapter 3: The importance of creating awareness around prevention and treatment of heart disease @Novartis
Chapter 3: The importance of creating awareness around prevention and treatment of heart disease  @Novartis
Uploaded March 2022 | Updated November 2026, 2 hours ago
In this video conversation series, Novartis Head of Global Drug Development and Chief Medical Officer Dr John Tsai and cardiologist Dr Steven Nissen discuss their perspectives and experiences around cardiovascular disease, the leading cause of death in the US. In Chapter 3 they speak about the importance of creating awareness around prevention and treatment of heart disease.

©2022 Novartis AG
Chapter 3: The importance of creating awareness around prevention and treatment of heart disease2023 HighlightsBridging barriers to healthcare: A blueprint for future global health part 4Bridging barriers to healthcare: A blueprint for future global health part 1Where One Step Leads – A Journey to Equitable HealthImmune Thrombocytopenia: Why Every Patient Voice MattersViaOpta SimImagine if you could switch jobs with anyoneLiving with neuroendocrine cancer – meet Rachael30 years of Novartis, powered by 250 years of innovationNext Generation Scientist 2023ISGlobal and Novartis: Co-creating solutions for people affected by Chagas disease
Novartis |

Chapter 3: The importance of creating awareness around prevention and treatment of heart disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER